Skip to main content
Clinical Trials/ITMCTR2000003976
ITMCTR2000003976Not yet recruitingPhase 1

Multi center randomized controlled clinical trial of Xiezhuo Tongluo Formula in the treatment of chronic kidney disease stage 3-4

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 75 (—)
Sex
All

Inclusion Criteria

  • (1) It met the diagnostic criteria of CKD3-4
  • (2) Aged 18 to 75 years old and can sign the informed consent form independently
  • (3) Blood pressure 100-160/60-100mmHg.

Exclusion Criteria

  • (1) Prepare for renal replacement therapy;
  • (2) Immunosuppressive therapy were performed;
  • (3) Patients with acute infection, serious primary diseases of heart, lung, brain, liver and hematopoietic system, diabetic ketoacidosis, malignant tumor, active tuberculosis and psychotic patients;
  • (4) eGFR fluctuated more than 30% in three months;
  • (5) Severe hyperkalemia (blood potassium>6.5mmol/L);
  • (6) Allergy history to some components of the drug used;
  • (7) Pregnant or during lactation;
  • (8) Participated in other clinical studies.

Investigators

Sponsor
The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Similar Trials